--- title: "MEC (TSE:4971) Net Margin Step Change Tests Justification For Premium P/E Multiple" type: "News" locale: "en" url: "https://longbridge.com/en/news/286344469.md" description: "MEC (TSE:4971) reported Q1 2026 revenue of ¥6.1 billion and net income of ¥1.5 billion, with a net margin of 26.8%, up from 10.9% a year prior. The company’s trailing P/E is 34.5x, significantly higher than peers at 16.3x, raising concerns about valuation risk given forecasts of only 4.0% annual earnings growth. While recent earnings growth of 205.8% is impressive, the long-term outlook appears more moderate with a 5-year compound growth rate of 9.7%. Investors are debating whether the current margins indicate a sustainable change or a peak performance." datetime: "2026-05-14T02:14:46.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286344469.md) - [en](https://longbridge.com/en/news/286344469.md) - [zh-HK](https://longbridge.com/zh-HK/news/286344469.md) --- # MEC (TSE:4971) Net Margin Step Change Tests Justification For Premium P/E Multiple MEC (TSE:4971) opened Q1 2026 with revenue of ¥6.1 billion and net income of ¥1.5 billion, translating into basic EPS of ¥83.68, while the trailing twelve months show revenue of ¥22.7 billion and EPS of ¥331.10 as the backdrop for this quarter’s print. The company has seen quarterly revenue move from ¥4.4 billion in Q1 2025 to ¥6.1 billion in Q1 2026, with basic EPS over that span shifting from ¥25.44 to ¥83.68. This highlights a narrative in which margins and earnings quality are a primary focus for investors. See our full analysis for MEC. With the headline numbers on the table, the next step is to compare them with the prevailing narratives investors follow to see which stories hold up and which ones the latest margins and growth trends begin to challenge. Curious how numbers become stories that shape markets? Explore Community Narratives TSE:4971 Revenue & Expenses Breakdown as at May 2026 ## TTM net margin climbs to 26.8% - On a trailing twelve month basis, MEC reports a net profit of ¥6,079.6 million on revenue of ¥22,651.1 million, which lines up with a net margin of 26.8% compared with 10.9% a year earlier. - What stands out for a bullish take is how this higher margin sits alongside trailing EPS of ¥331.10 and revenue growth of 9.6% per year. At the same time, forecasts point to earnings growth of about 4.0% per year, which raises the question of how much of the recent 205.8% earnings jump is repeatable. - Bulls often point to high reported earnings quality and the step up in margin to 26.8% as signs that the business is converting revenue into profit efficiently, on top of the ¥1,528 million Q1 2026 net income. - At the same time, the gap between the recent very large earnings increase and the more modest 5 year compound rate of 9.7% per year suggests a more measured long term profile, which bullish investors need to factor in when thinking about durability. Some investors are asking whether these margins signal a lasting step change or a high point in a strong year, and a full narrative helps put these numbers in context before you make that call. **📊 Read the what the Community is saying about MEC.** ## Premium P/E of 34.5x versus peers - MEC trades on a trailing P/E of 34.5x, compared with 16.3x for peers and 14.3x for the broader JP Chemicals industry, while the current share price of ¥11,480 sits close to a stated DCF fair value of ¥11,414.26. - Critics highlight that such a premium multiple rests on strong trailing metrics like 205.8% year over year earnings growth and a 26.8% net margin. However, forecasts for about 4.0% annual earnings growth and 9.6% annual revenue growth leave bears questioning whether the current 34.5x P/E gives enough room for any disappointment. - The tension is that MEC’s revenue profile, at 9.6% per year and ahead of the JP market’s 6.1%, supports the idea of a solid business, but not necessarily one that must trade at more than double the industry P/E of 14.3x. - For a cautious view, the combination of a premium P/E, a trailing EPS of ¥331.10 and a share price above the single available analyst target of ¥8,900.00 can be read as valuation risk if future earnings growth tracks the lower forecast pace rather than the recent very strong year. ## Earnings trend from Q1 2025 to Q1 2026 - Across the last five reported quarters, total revenue moved from ¥4,423.9 million in Q1 2025 to ¥6,128.0 million in Q1 2026, while basic EPS over the same stretch went from ¥25.44 to ¥83.68 against intervening quarterly EPS figures of ¥76.16, ¥78.42 and ¥92.92. - What is interesting for a bullish story is that this sequence of quarterly EPS readings supports the trailing EPS of ¥331.10. At the same time, the five year compound earnings growth rate of 9.7% per year and forward earnings growth expectation of about 4.0% per year show a more moderate long run profile than the recent 205.8% year over year surge might suggest. - Supporters of the bullish angle can point to Q1 2026 net income of ¥1,528 million versus ¥476.4 million in Q1 2025 as part of the broader trailing twelve month net income figure of ¥6,079.6 million, which underpins the current EPS base the forecasts build from. - At the same time, the trailing twelve month revenue of ¥22,651.1 million versus ¥18,234.0 million a year earlier shows a steady revenue platform that aligns with the 9.6% growth rate, giving bulls a revenue trend to match the earnings numbers they are highlighting. ## Next Steps Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on MEC's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move. With sentiment in this article pulling in both bullish and cautious directions, it makes sense to check the data yourself and quickly form your own view. To balance the upside and downside discussed here, take a closer look at the 2 key rewards and 1 important warning sign. ## See What Else Is Out There MEC carries a premium 34.5x P/E and trades above the sole analyst target, while forward earnings growth expectations sit well below the recent very large jump. If that mix of rich valuation and modest forecast growth feels tight, compare it with companies that screen as potentially better value using the 13 high quality undervalued stocks. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### **New:** Manage All Your Stock Portfolios in One Place We've created the **ultimate portfolio companion** for stock investors, **and it's free.** • Connect an unlimited number of Portfolios and see your total in one currency • Be alerted to new Warning Signs or Risks via email or mobile • Track the Fair Value of your stocks Try a Demo Portfolio for Free ### Related Stocks - [4971.JP](https://longbridge.com/en/quote/4971.JP.md) ## Related News & Research - [Mayville Engineering Company Named Number One Fabricator for Sixteenth Consecutive Year | MEC Stock News](https://longbridge.com/en/news/288459694.md) - [EDM Commences Trading on OTCQB Venture Market Under Symbol EDMFF | EDMFF Stock News](https://longbridge.com/en/news/288416375.md) - [Rabo On Regime-Change At The Fed: What Warsh Can (And Should) Do First](https://longbridge.com/en/news/288604862.md) - ['Working From Home Is Career Suicide,' Skims Co-Founder Emma Grede Says As She Warns Of 'Loneliness Epidemic' And 'Declining Birth Rates'](https://longbridge.com/en/news/287971099.md) - [US Adult Cigarette Smoking Rate Hits Another All-Time Low](https://longbridge.com/en/news/288249323.md)